Each time 25 year old Salma takes her one year old son Zubair to the Batla Clinic (a private clinic in Delhi) for a shot of the DPT, the cost of transportation and the vaccine adds up to approximately Rs.500.   When it is time for Zubair to take the next immunization dose, Salma may find that the expenses have entirely spiraled out of her reach. New vaccines and expensive brands of baby...

The World Health Organization (WHO) on Monday warned India that feminization of its ageing population could lead to a rapid increase in its number of widows. Reacting to a TOI story that showed how the majority of India's elderly are now women, WHO's representative to India Dr Nata Menabde said the trend has significant consequences for the health of older women. She said, "Women's longer life-spans compared to men, combined with the...

-PTI   Setting a precedent before his cabinet colleagues, Uttar Pradesh Chief Minister Akhilesh Yadav has officially declared his assets and liabilities worth over Rs 4.83 crore.  Akhilesh, 38, who uploaded details of his assets and liabilities on the official website of the state government, is the first Uttar Pradesh Chief Minister to make a public declaration.  In the 2009 Lok Sabha elections when Akhilesh filed his nomination papers for Kannauj parliamentary seat, he...

-Reuters   Cheap generic drugs were meant to change the life of Nandakhu Nissar, whose mouth is swollen by a cancerous tumour. But the cashless and hungry 55-year-old sleeps on a pavement staring up at the windows of Mumbai's biggest cancer hospital.  "What is a generic drug?" shrugs Nissar, who has travelled over 1,500 kms (900 miles) from his home in the hope of treatment. "I have borrowed money from friends and relatives...

Compulsory licence can go a long way to ensure access to cheaper drugs In a momentous development, the Indian patent office issued the ever-compulsory licence in a highly contentious pharmaceutical patent case. The decision is a thumping victory for several patients and health activists who have been fighting what can only be labelled as highly inequitable pricing strategies by multinational drug firms for the past several decades. In August 2011, Natco, an...